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ABSTRACT We have used antibodies to human thrombomodulin isolated from placenta to 
investigate the distribution of this cofactor for protein C activation in human tissues. Throm- 
bomodulin was found on endothelial cells of arteries, veins, capillaries, and lymphatics by 
immunocytochemical staining using an avidin-biotin peroxidase method. Thrombomodulin 
was not detected on sinusoidal lining cells of liver or on postcapillary high-endothelial venules 
of lymph node, although the latter contained another endothelial antigen, von Willebrand 
factor. Other cells noted to contain thrombomodutin antigen are those of the syncytiotro- 
phoblast in placenta. The thrombomodulin in syncytiotrophoblast was primarily on the plasma 
membrane surface that forms the maternal blood sinus. Syncytiotrophoblast also stained with 
antibodies to von Willebrand factor, which implies that these cells have multiple endothelial 
functions. Thrombomodulin antigen was found in all organs studied, with the notable excep- 
tion of brain. 
Endothelium has the important function of maintaining 
blood fluidity. This is accomplished in part by the production 
of the icosanoid mediator PGI2 in response to endothelial 
injury (2), thrombogenic stimuli such as thrombin (24), or 
inflammatory mediators such as histamine (l) and bradykinin 
(17). PGI2 acts as a vasodilator and inhibits platelet activation 
(3). Recently, other endothelial factors that inhibit coagula- 
tion reactions have been described. These include heparin- 
like molecules on the cell surface that act as a cofactor for 
anti-thrombin III in inhibiting several coagulation factor pro- 
teases (13), and the cell surface protein, thrombomodulin, 
that acts as a cofactor for thrombin-catalyzed activation of 
protein C. Activated protein C inhibits coagulation by inac- 
tivating factors Va and VIIIa. Thrombomodulin was first 
isolated from detergent extracts of rabbit lung by affinity 
chromatography on thrombin-Sepharose (5-8). The protein 
was postulated to be of endothelial origin since perfusion of 
thrombin and protein C through rabbit vessels led to accel- 
erated rates of protein C activation (6). A similar protein was 
thought to be present in humans since accelerated rates of 
thrombin-catalyzed protein C activation could also be dem- 
onstrated in the presence of intact human umbilical vein 
endothelial cells in culture (6), and antibodies directed against 
rabbit thrombomodulin partially inhibited protein C activa- 
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Lion on human cells (15). The existence of thrombomodulin 
in human tissues has been recently established by the isolation 
of the protein from extracts of human placenta. Human 
thrombomodulin is similar but not identical to the rabbit 
protein (14, 20). Thus, human thrombomodulin activity is 
stimulated by coagulation factor Va and its isolated light 
chain. We have recently prepared antibodies against human 
thrombomodulin. Using these antibodies, we have studied 
the tissue distribution of thrombomodulin. Using an avidin- 
biotin immunoperoxidase method, we now report that throm- 
bomodulin is found in most human endothelium including 
that of arteries, veins, capillaries, and lymphatics. Another 
cell type found to contain thrombomodulin is the placental 
syncytiotrophoblast. This cell has also been found to contain 
yon Willebrand factor antigen, another marker of endothe- 
lium. 
MATERIALS AND METHODS 
Except when indicated, all reagents were purchased from Sigma Chemical Co. 
(St. Louis, MO). Human thrombin (16), human protein C (22), and anti- 
thrombin IIl (18) were isolated from human plasma as described. Anti-human 
von Willebrand factor rabbit lgG was purchased from Dako Corp. (Santa 
Barbara, CA). Nitrocellulose sheets were purchased from Bio-Rad Laboratories 
(Richmond, CA). 
363 Preparation of Anti-thrombomodulin IgG:  Two male  rabbits 
were immunized intradermally at 300 sites with 60 #g each of  thrombomodulin 
in complete Freund's adjuvant  by the method of Vaitukaitis (23). After 2 mo, 
potent antiserum was obtained. Anti-thrombomodulin IgG or control IgG was 
isolated using protein  A-Sepharose  (Pharmacia  Fine Chemicals, Piscataway, 
N  J) as follows: 5 ml of the anti-thrombomodulin serum or control serum was 
applied  on  a  protein  A-Sepharose  column  (1  x  5  cm) equilibrated  with 
phosphate-buffered  saline (PBS; l0 mM phosphate,  0.15 M  NaCl, pH 7.4). 
After the column was washed with 50 ml of PBS, lgG was eluted with 0. l M 
glycine, pH 3, and immediately  dialyzed against the buffer with 20 mM Tris- 
HCI, 0.15 M NaCI, pH 7.4. 0.05 pmol human thrombomodulin isolated from 
placenta was incubated with 0-10 pg of anti-thromhomodulin IgG for 15 min 
at  37"C, and then cofactor  activity  of the thrombomodulin was assayed in 
reaction mixtures containing  1.0 pM protein C and 40 nM thrombin in a total 
volume of 30 pl 20 mM Tris-HCI, pH 7.4, 0.15 M NaC1, l mM CaCl2, and 5 
mg/ml bovine serum albumin (BSA). Protein C activation was terminated  by 
addition  of 40 U/ml hirudin and 350 pg/ml anti-thrombin III. The amount of 
activated protein C was assayed by measuring the rate of hydrolysis of 0.2 mM 
o-Phe-pipecolyl-Arg-p-nitroanilide ($2238, Kabi Diagnostica, Sweden). 
Immunoblot of Thrombomodulin:  Sodium dodecyl sulfate pol- 
yacrylamide gel electrophoresis (SDS PAGE) was performed by the method of 
Laemmli (l l) using 4% acrylamide in the stacking and 10% acrylamide in the 
running gel. Samples of placental thrombomodulin were electrophoresed with 
2-mereaptoethanol.  Immunoblotting  was performed by the method of Burnett~ 
(4). Anti-thrombomodulin serum was used at a  1:250 dilution,  and detection 
was made using ~2~I-protein A and autoradiography. 
Cell Cultures and the Functional  Assay of Thrombomodulin 
Activity:  Primary cultures of human umbilical vein endothelial  cells were 
prepared as previously described (10). One of the human choriocarcinoma  cell 
lines, JAr, was provided by Dr. Irving Boime, Washington University, and the 
other,  BeWo, was from American  Type Culture  Collection. These cells were 
cultured  in plastic  30-100-mm  petri  dishes  or 6-16-mm  multi-well plates. 
Protein C activation was examined on these cells as previously described (15). 
The cultured cells were also used for immunochemical  study. 
Tissue Preparation:  Tissues (excluding placenta)  fixed in  10%  for- 
malin buffered with 0.1  M calcium acetate, pH 7.4, for a minimum of 24 h, 
were obtained  from  the  autopsy  pathology  service.  Placenta  fixed in  10% 
formalin buffered with 0.15 M sodium acetate, pH 7.0, for a minimum of 24 
h, was obtained from the surgical pathology service. Tissues were embedded in 
paraffin,  and 6-/am-thick sections were cut and placed on microscope  slides 
that  had  been  cleaned  with  10%  potassium  dichromate,  1%  sulfuric  acid 
solution, and coated with 0.25% gelatin containing 0.05% chrome alum as an 
adhesive (19). Sections were then dried at 60"C and stored at room temperature. 
Immunocytochemistry:  Sections were de-waxed in 100% xylene for 
l0 min with one change, and rehydrated in 100% isopropyl alcohol for l0 min 
with one change, 70% isopropyl alcohol for 5 min, and PBS for 15 min with 
two changes. Rabbit  anti-thrombomodulin serum and control  rabbit  serum 
were diluted  l:l,000;  rabbit  anti-thrombomodulin IgG and  normal control 
rabbit  IgG were diluted  to  l0 pg/ml; and rabbit anti-von Willebrand  factor 
lgG and its control  rabbit  IgG were diluted  to 20 pg/ml. All dilutions  were 
made in 10% normal human serum in PBS. Diluted reagents were centrifuged 
at 20,000 g for 20 rain to remove any large aggregates. Normal human serum 
provided optimal blocking of nonspecific staining compared with normal goat 
serum or no serum,  with  no impairment of specific staining.  For anti-von 
Willebrand  factor staining,  sections were preincubated  with 0.025%  trypsin 
(KC Biological Inc., Lenexa, KS) in 0.1% CaCl2, 0.05 M Tris-HC1,'  pH 7.6 for 
30 rain at 37"C. This was necessary in order to expose von Willebrand factor 
antigenic determinants  in formalin-fixed tissue. Thrombomodulin staining was 
unaffected by the trypsin  preincubation.  These sections were then washed in 
PBS for  15  min with  two changes. All  sections were incubated  with  either 
antiserum, immune IgG, or control preparations for 16-20 h at 4"C in a humid 
atmosphere,  gently washed  in  PBS for 15  min with two changes, and then 
incubated with biotinylated affinity-purified goat anti-rabbit immunoglobulin 
(Vector Laboratories, Inc., Burlingame, CA) for 30 min at room temperature. 
The latter reagent was diluted to the recommended  concentration  (45 #l in  10 
ml) in  10% normal human serum in PBS. Sections were again gently washed 
in  PBS  for  15  min  with  two changes,  incubated  with  avidin-biotinylated 
horseradish  peroxidase complex  (ABC reagent, Vector  Laboratories,  Inc.) at 
the recommended  concentration  (90 pl avidin and 90 ul biotinylated horserad- 
ish peroxidase in 10 ml PBS, allowed to incubate for 30 min before use) for 45 
min, washed in PBS for 5 min and  100 mM Tris-HCl buffer, pH 7.2, for 10 
min with one change. After incubation  in 0.05% diaminobenzidine  tetrahy- 
drochloride, 0.01% H202 in Tris-HCl buffer, pH 7.2, for 5 min, sections were 
washed in the Tris-HCl buffer for 10 min with one change and in deionized 
water for 5 min. Sections were then counter-stained in 0.5 % Harris hematoxylin 
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(21) for 2 min, differentiated by quick dipping in acid alcohol (1% HCI, 70% 
ethanol), and blued in gently running tap water for 5 min. Sections were finally 
dehydrated in 70% isopropyl alcohol for 5 min, 100% isopropyl alcohol for 10 
min with  one change, and  100% xylene for  l0 min with  one change, and 
mounted in Permount. Cultured cells of  monolayers were also fixed and stained 
as described above. 
5pecific Absorption of Antibodies:  Thespecificityofanti-throm- 
bomodulin lgG and anti-von Willebrand factor IgG was established by absorp- 
tion with the respective purified antigens. Anti-thrombomodulin lgG (20 pg/ 
ml) was incubated with 30 pg thrombomodulin/ml (threefold excess) isolated 
from human placenta for 24 h at 4"C and then centrifuged at 20,000 g for 30 
min and the supernatant  collected and used for immunohistochemistry.  Anti- 
von Willebrand factor lgG (20 pg/ml) was incubated with 25 t~g yon Willebrand 
factor/ml  as described above. The concentration  of von Willebrand factor was 
five times that required to neutralize the antibody.  The protein  was homoge- 
neous as determined  by SDS PAGE  and was a  gift from Drs.  Evan  Sadler 
(Washington  University)  and  Earl  Davie  (University  of Washington).  The 
respective antisera were also absorbed with human serum albumin as a control. 
Sections of human placenta were stained using these absorbed lgG solutions as 
described above. 
RESULTS 
Characterization of Polyclonal Anti- 
Thrombomodulin IgG 
The polyclonal rabbit anti-thrombomodulin IgO used in 
these experiments binds thrombomodulin as shown by im- 
munoblotting (Fig. 1). We assayed the affinity of  the antibody 
for thrombomodulin by measuring its ability to block protein 
C activating cofactor activity as described in Materials and 
Methods.  The  apparent  /G  of the  IgG  was  22  nM  with 
complete inactivation of thrombomodulin at concentrations 
of 33 pg/ml (320 nM). 
FIGURE  1  Immunoblot  of 
thrombomodulin  from  pla- 
centa.  The  immunoblot  was 
performed  as  described  in 
Materials and  Methods.  Lane 
1, 100 ng; lane 2, 200 ng; lane 
3, 400 ng of thrombomodulin. Immunohistochemical  Localization 
of Thrombomodulin 
In all the studies reported here, the anti-thrombomodulin 
IgG was incubated with  sections at  10-20/~g/ml that gave 
maximal staining as determined in preliminary experiments 
using sections of placenta. The IgG absorbed with purified 
placental  thrombomodulin,  as  described  in  Materials  and 
Methods, gave no staining of sections from placenta, indicat- 
ing that the antigen detected was thrombomodulin. 
We examined a variety of human tissues for the presence 
of thrombomodulin antigen by an avidin-biotin peroxidase 
method.  We  found  that  endothelial  cells were positive for 
thrombomodulin in most tissues examined as summarized in 
Table I. Endothelium stained in a thin continuous line sug- 
gesting a surface localization, although we cannot be sure of 
the intracellular distribution of the antigen with the current 
techniques. Endothelium in veins, arteries, and capillaries all 
stained. Cultured endothelial cells from umbilical cord vein 
also  stained  (data  not  shown).  Other  cells  that  contained 
thrombomodulin antigen were those of the syncytiotropho- 
blast in placenta (see below). The pattern ofthrombomodulin 
staining  of endothelium  is  illustrated  in  Fig.  2.  Coronary 
artery,  and  an  arteriole  and  vein  from  lung  are  depicted. 
Staining controls using nonimmune rabbit IgG were negative 
(Fig.  2, a, c, and e). The stain observed in erythrocytes and 
granulocytes  is  due  to  endogenous  peroxidase  activity.  In 
several tissues, including the gastrointestinal tract and lymph 
nodes, we noted that lymphatic endothelium contains throm- 
bomodulin.  This is apparent in the section of lymph node 
shown in Fig.  3, a  and b.  There was prominent staining of 
the subcapsular lymphatic endothelium (Fig. 3 b). Some types 
of endothelium apparently do not contain thrombomodulin. 
These include hepatic sinusoids, and most strikingly, brain. 
We examined multiple sections from two brains and found 
only scant  thrombomodulin  staining.  The high-endothelial 
venules of lymph node also appear to lack thrombomodulin 
antigen as shown in Fig.  4.  Adjacent sections were stained 
after exposure to either anti-thrombomodulin  (Fig.  4c)  or 
anti-yon Willebrand factor IgG (Fig. 4b). It is apparent that 
lymphatic endothelium (solid arrows, Fig.  4a, clear arrows, 
Fig.  4b) contains thrombomodulin but not von Willebrand 
factor.  The high-endothelial  venules (clear arrows,  Fig.  4a, 
solid arrows, Fig. 4b) show the opposite pattern of staining; 
that is, thrombomodulin is absent and von Willebrand factor 
is present. 
Thrombomodulin and yon  Willebrand Factor 
Antigen in Placenta 
We previously observed that placenta has a high content of 
thrombomodulin based upon the protein C activating cofactor 
activity of crude extracts (20). The immunohistochemistry of 
this  organ  gave  a  surprising  result.  The  most  prominent 
staining was observed in syncytiotrophoblast as shown in Fig. 
5. There was also staining of capillary endothelium. In some 
areas it appeared that stromal cells stained with anti-throm- 
bomodulin.  We are uncertain  as to the significance of this 
finding; possibly these are endothelial precursors. The staining 
of the syncytiotrophoblast was primarily linear along the cell 
surface  exposed  to  maternal  blood.  While  these  cells  are 
known to be hormone producing, it is not surprising that they 
also contain thrombomodulin since, like endothelium, they 
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TABLE I.  Immunoperoxidase  Localization of Thrombomodulin 
Other findings 
Organs displaying endothelial 
thrombomodulin in arter- 
ies, veins, and capillaries 
Lung 
Heart 
Liver 
Kidney 
Pancreas 
Thyroid 
Colon 
Spleen 
Adrenal 
Lymph node 
Aorta 
Vena cava 
Spleen 
Skeletal muscle 
Duodenum 
Stomach 
Esophagus 
Placenta 
Organ with trace or absent 
thrombomodulin in endo- 
thelium 
Brain 
Endocardium (+) 
Sinusoids (-) 
Glomerular capillary (+) 
Lymphatics (+) 
Lymphatic (+) 
Postcapillary venule (-) 
Endothelium (+) 
Endothelium  (+) 
Lymphatics (+) 
Lymphatics (+) 
Syncytiotrophoblast  (+) 
Occasional positive vein or 
capillary 
are exposed to blood. In view of this finding, we also stained 
sections of placenta using  an  anti-human  von  Willebrand 
factor rabbit IgG. This antigen is a  marker of endothelium 
and is also present on syncytiotrophoblast as shown in Fig. 6. 
However, two cell lines of  human chorionic carcinoma, BeWo 
and JAr, had neither thrombomodulin activity nor von Wil- 
lebrand factor antigen. That staining with the anti-von Wil- 
lebrand factor IgG was specific for this antigen was established 
by showing that sections of human placenta stained with von 
Willebrand  factor-absorbed IgG showed  no  endothelial  or 
syncytiotrophoblast staining. 
DISCUSSION 
In the present investigation, we have established that throm- 
bomodulin  is widely distributed  on  vascular endothelium. 
This localization well serves its putative function as a cofactor 
for protein C activation. Activated protein C is a physiological 
anticoagulant  that  inactivates  factors  Va  and  VIIIa  and 
thereby maintains blood fluidity.  That lymphatic endothe- 
lium also contains thrombomodulin may also be of physio- 
logical importance. Lymph contains coagulation factors and 
can clot (12). Therefore, thrombomodulin in lymph may serve 
to  ensure  its  fluidity.  Similarly,  the  syncytiotrophoblast of 
placenta is exposed to relatively stagnant blood, and throm- 
bomodulin in this site may be important in blocking coagu- 
lation in maternal blood sinuses. The finding that these pla- 
cental cells also contain another endothelial-specific antigen, 
von Willebrand factor, is further evidence that these cells are 
endothelial  despite their well known endocrine  function.  If 
thrombomodulin is important in the placenta, disorders in its 
function might lead to diseases such as recurrent abortion. 
We  plan  to  screen  the  plasma  of patients  with  recurrent 
abortions  for inhibitors  of thrombomodulin.  Alternatively, 
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ization of thrombomodulin by an 
avidin-biotin  immunoperoxidase 
method. (a) Coronary artery with 
control  IgG; (b)  coronary artery 
with  anti-thrombomodulin  IgG; 
(c) lung arteriole  with control IgG; 
(d) lung arteriole  with anti-throm- 
bomodulin IgG; (e) lung vein with 
control  IgG;  (f)  lung  vein  with 
anti-thrombomodulin IgG. Posi- 
tive  staining  of  endothelium  is 
shown by arrows, x  500. 
366  THE  JOURNAL OF  CELL BIOLOGY - VOLUME  101,  1985 FIGURE  3  Immunoperoxidase  staining of subcapsular  lymphatic sinus of lymph node. (a) Control IgG; (b) anti-thrombomodulin 
IgG. The endothelium of the lymphatic sinus and of its trabecular meshwork (arrows) is stained,  x  500. 
MARUYAMA ET AL.  Thrombornodulin Is Found on Endothelium and Syncytiotrophoblast  367 FIGURE 4  Immunoperoxidase staining of postcapillary high-endothelial venules of lymph node. (a) Anti-thrombomodulin IgG; 
(b) anti-von Willebrand factor IgG. With anti-thrombomodulin IgG (a) there is a positive staining of endothelium (solid arrows) 
but not of endothelium from postcapillary high-endothelial venules (open arrows). With anti-von Willebrand factor IgG (b) there 
is positive staining of postcapillary high endothelial venules (solid arrows) but not of lymphatic endothelium (open arrows), x  500. 
368 FIGURE  5  Immunoperoxidase staining of syncytiotrophoblast in placenta. (a) Control  IgG; (b)  anti-thrombomodulin IgG.  The 
staining is prominent on  syncytiotrophoblast as shown  by the large arrows in  b.  Capillary endothelium (mid-size arrows) and 
stromal cells (small arrows) stained (b). x  500. 
MARUYAMA ET AL.  Thrombomodulin  Is Found on Endothelium  and Syncytiolrophoblast  369 FIGURE  6  Presence of von Willebrand factor antigen on syncytiotrophoblast. (a) Control IgG; (b) anti-yon Willebrand factor IgG. 
x  500. The staining pattern is similar to that with anti-thrombomodulin IgG. x  500. 
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antigen in tissue from spontaneous abortions. 
We also demonstrated that thrombomodulin is not present 
on the sinusoidal lining cells of liver or on postcapillary high- 
endothelial  venules  of lymph  node.  In contrast,  von  Wille- 
brand factor antigen is on postcapillary venules but not lym- 
phatic endothelium of lymph node. This striking observation 
is difficult to explain, but may somehow relate to the function 
of  the  high  endothelium.  Lymphocytes  migrate  from  the 
blood into lymph nodes through these specialized endothelial 
cells (9). 
We have no explanation for the finding that brain appears 
deficient  in  thrombomodulin.  We  do  not  believe  that  the 
absence  of histochemical  identification  of thrombomodulin 
in brain results from an artifact of our procedure. In experi- 
ments  where  we  used  a  radioimmunoassay  of crude  tissue 
homogenates  of  brain  and  other  organs  to  estimate  total 
thrombomodulin  content,  we found  no thrombomodulin in 
brain  tissue,  whereas  it  was  present  in  many  other  organs 
assayed. Thrombomodulin was found in homogenates of large 
arteries that  supply  the  brain  (carotid,  basilar;  unpublished 
observation). 
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